NCT04050956 French Cohort of Myocardial Infarction Evaluation
| NCT ID | NCT04050956 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Acute Myocardial Infarction |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2019-03-11 |
| Primary Completion | 2029-03-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 2019-03-11 with a primary completion date of 2029-03-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Over the last two decades, considerable progress has been made in the management of Acute Myocardial Infarction (AMI), both in the acute phase and in monitoring beyond the hospital phase. Nevertheless, the evolution of care practices and their impact on the mid- and long-term prognosis of patients admitted to the intensive care unit for acute myocardial infarction remain relatively little studied exhaustively. The aim of this study is to assess the profile of AMI patients, their management and follow-up in order to evaluate the relationship between these factors and outcomes.
Eligibility Criteria
Inclusion Criteria: * Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical increased or fall of troponin (or CPKMB) associated with at least one of the following elements : * Symptoms compatible with myocardial ischemia * Appearance of pathological Q waves * ST- T changes compatible with myocardial ischemia (ST segment elevation or depression, T-wave inversion) * Written consent. * Covered by French medical insurance ("Sécurité Sociale") Exclusion Criteria: * Iatrogenic MI defined as MI occurring within 48h of a therapeutic procedure * AMI diagnosis invalidated in favor of another diagnosis
Contact & Investigator
Philippe Gabriel STEG
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT04050956 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04050956 currently recruiting?
Yes, NCT04050956 is actively recruiting participants. Contact the research team at tabassome.simon@aphp.fr for enrollment information.
Where is the NCT04050956 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT04050956 clinical trial?
NCT04050956 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Philippe Gabriel STEG at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 30,000 participants.